"Mucolipidoses" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of inherited metabolic diseases characterized by the accumulation of excessive amounts of acid mucopolysaccharides, sphingolipids, and/or glycolipids in visceral and mesenchymal cells. Abnormal amounts of sphingolipids or glycolipids are present in neural tissue. INTELLECTUAL DISABILITY and skeletal changes, most notably dysostosis multiplex, occur frequently. (From Joynt, Clinical Neurology, 1992, Ch56, pp36-7)
| Descriptor ID |
D009081
|
| MeSH Number(s) |
C05.116.198.371 C10.228.140.163.100.435.590 C16.320.565.189.435.590 C16.320.565.202.670 C16.320.565.595.554.590 C18.452.132.100.435.590 C18.452.648.189.435.590 C18.452.648.202.670 C18.452.648.595.554.590
|
| Concept/Terms |
Type I Mucolipidosis- Type I Mucolipidosis
- Mucolipidoses, Type I
- Mucolipidosis, Type I
- Type I Mucolipidoses
- Glycoprotein Neuraminidase Deficiency
- Deficiencies, Glycoprotein Neuraminidase
- Deficiency, Glycoprotein Neuraminidase
- Glycoprotein Neuraminidase Deficiencies
- Cherry Red Spot-Myoclonus Syndrome
- Myoclonus-Cherry Red Spot Syndrome
- Mucolipidosis Type I
- Mucolipidosis I
- Cherry Red Spot Myoclonus Syndrome
- Myoclonus Cherry Red Spot Syndrome
- Mucolipidosis Type 1
Type III Mucolipidosis- Type III Mucolipidosis
- Mucolipidoses, Type III
- Mucolipidosis, Type III
- Type III Mucolipidoses
- Mucolipidosis III
- Pseudo-Hurler Polydystrophy
- Polydystrophy, Pseudo-Hurler
- Pseudo Hurler Polydystrophy
- Mucolipidosis IIIa
- Mucolipidosis III Alpha Beta
- Mucolipidosis Type III
- Psuedo-Hurler Disease
- Psuedo Hurler Disease
- Psuedo-Hurler Diseases
Type IV Mucolipidosis- Type IV Mucolipidosis
- Mucolipidoses, Type IV
- Mucolipidosis, Type IV
- Type IV Mucolipidoses
- Deficiency Disease, Ganglioside Sialidase
- Ganglioside Sialidase Deficiency Disease
- Sialolipidosis
- Sialolipidoses
- Mucolipidosis Type IV
- Mucolipidosis IV
Type II Mucolipidosis- Type II Mucolipidosis
- Mucolipidoses, Type II
- Mucolipidosis, Type II
- Type II Mucolipidoses
- I-Cell Disease
- I Cell Disease
- I-Cell Diseases
- Mucolipidosis Type II
- Inclusion Cell Disease
- Inclusion Cell Diseases
- Mucolipidosis II
|
Below are MeSH descriptors whose meaning is more general than "Mucolipidoses".
- Diseases [C]
- Musculoskeletal Diseases [C05]
- Bone Diseases [C05.116]
- Bone Diseases, Metabolic [C05.116.198]
- Mucolipidoses [C05.116.198.371]
- Nervous System Diseases [C10]
- Central Nervous System Diseases [C10.228]
- Brain Diseases [C10.228.140]
- Brain Diseases, Metabolic [C10.228.140.163]
- Brain Diseases, Metabolic, Inborn [C10.228.140.163.100]
- Lysosomal Storage Diseases, Nervous System [C10.228.140.163.100.435]
- Mucolipidoses [C10.228.140.163.100.435.590]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Metabolism, Inborn Errors [C16.320.565]
- Brain Diseases, Metabolic, Inborn [C16.320.565.189]
- Lysosomal Storage Diseases, Nervous System [C16.320.565.189.435]
- Mucolipidoses [C16.320.565.189.435.590]
- Carbohydrate Metabolism, Inborn Errors [C16.320.565.202]
- Mucolipidoses [C16.320.565.202.670]
- Lysosomal Storage Diseases [C16.320.565.595]
- Lysosomal Storage Diseases, Nervous System [C16.320.565.595.554]
- Mucolipidoses [C16.320.565.595.554.590]
- Nutritional and Metabolic Diseases [C18]
- Metabolic Diseases [C18.452]
- Brain Diseases, Metabolic [C18.452.132]
- Brain Diseases, Metabolic, Inborn [C18.452.132.100]
- Lysosomal Storage Diseases, Nervous System [C18.452.132.100.435]
- Mucolipidoses [C18.452.132.100.435.590]
- Metabolism, Inborn Errors [C18.452.648]
- Brain Diseases, Metabolic, Inborn [C18.452.648.189]
- Lysosomal Storage Diseases, Nervous System [C18.452.648.189.435]
- Mucolipidoses [C18.452.648.189.435.590]
- Carbohydrate Metabolism, Inborn Errors [C18.452.648.202]
- Mucolipidoses [C18.452.648.202.670]
- Lysosomal Storage Diseases [C18.452.648.595]
- Lysosomal Storage Diseases, Nervous System [C18.452.648.595.554]
- Mucolipidoses [C18.452.648.595.554.590]
Below are MeSH descriptors whose meaning is more specific than "Mucolipidoses".
This graph shows the total number of publications written about "Mucolipidoses" by people in this website by year, and whether "Mucolipidoses" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mucolipidoses" by people in Profiles.
-
50 Years Ago in TheJournalofPediatrics: I-Cell Disease: The More Things Change, the More They Stay the Same. J Pediatr. 2021 Sep; 236:291.
-
Pathogenic STX3 variants affecting the retinal and intestinal transcripts cause an early-onset severe retinal dystrophy in microvillus inclusion disease subjects. Hum Genet. 2021 Aug; 140(8):1143-1156.
-
Intermittent enzyme replacement therapy with recombinant human ?-galactosidase prevents neuraminidase 1 deficiency J Biol Chem. 2020 09 25; 295(39):13556-13569.
-
Editing Myosin VB Gene to Create Porcine Model of Microvillus Inclusion Disease, With Microvillus-Lined Inclusions and Alterations in Sodium Transporters. Gastroenterology. 2020 06; 158(8):2236-2249.e9.
-
TRPML1 links lysosomal calcium to autophagosome biogenesis through the activation of the CaMKK?/VPS34 pathway. Nat Commun. 2019 12 10; 10(1):5630.
-
Loss of MYO5B Leads to Reductions in Na+ Absorption With Maintenance of CFTR-Dependent Cl- Secretion in Enterocytes. Gastroenterology. 2018 12; 155(6):1883-1897.e10.
-
Villin immunohistochemistry is a reliable method for diagnosing microvillus inclusion disease. Am J Surg Pathol. 2015 Feb; 39(2):245-50.
-
Outcomes after hematopoietic stem cell transplantation for children with I-cell disease. Biol Blood Marrow Transplant. 2014 Nov; 20(11):1847-51.
-
New targets for old diseases: lessons from mucolipidosis type II. EMBO Mol Med. 2013 Dec; 5(12):1801-3.
-
TRPML: transporters of metals in lysosomes essential for cell survival? Cell Calcium. 2011 Sep; 50(3):288-94.